© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 22, 2020
Hope S. Rugo, MD, discusses the results of the phase 3 KEYNOTE-522 trial in triple-negative breast cancer (TNBC).
May 21, 2020
May 19, 2020
Hope S. Rugo, MD, discusses recent updates with immunotherapy in triple negative breast cancer.